What is Medtronic's equity method investment impairment?

Medtronic (MDT) reported equity method investment impairment of $0.00 in Q4 2025.

What does equity method investment impairment mean?

A loss recorded when the value of an investment in an associate or joint venture has permanently declined.

Discontinued — last reported Q4 '17

Equity Method Investment Impairment

Medtronic Equity Method Investment Impairment decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement

SectionOther Income & Expense

CategoryRisk

SignalLower is better

VolatilityVolatile

First reportedQ1 2017

Last reportedQ4 2017

How to read this metric

An increase indicates deteriorating performance or asset quality within the company's unconsolidated investment portfolio.

Detailed definition

Represents the non-cash charge recognized when the carrying value of an investment in an unconsolidated entity exceeds i...

Peer comparison

Commonly reported as 'Impairment of Equity Method Investments' or 'Loss on Investment' by peers in real estate and holding companies.

Metric ID: is_ms_equity_method_investment_impairment

Historical Data

3 periods

	Q4 '23	Q4 '24	Q4 '25
Value	$0.00	$71.00M	$0.00
QoQ Change	—	—	-100.0%
YoY Change	—	—	-100.0%

Range$0.00 – $71.00M

Avg YoY Growth-100.0%

Median YoY Growth-100.0%

Frequently Asked Questions

What is Medtronic's equity method investment impairment?: Medtronic (MDT) reported equity method investment impairment of $0.00 in Q4 2025.
What does equity method investment impairment mean?: A loss recorded when the value of an investment in an associate or joint venture has permanently declined.